Introduction of sugammadex as standard reversal agent: Impact on the incidence of residual neuromuscular blockade and postoperative patient outcome

by Thomas Ledowski, Samuel Hillyard, Brendan O′Dea, Rob Archer, Filipe Vilas-Boas, Barney Kyle
Published 2013-01-01